Briefing Note for SARS-CoV-2 Vaccine Related Changes
A briefing note providing a summary of the Severe acute respiratory syndrome coronavirus 2 vaccine-related changes made for the 2021-January International Release is available:
Atlassian uses cookies to improve your browsing experience, perform analytics and research, and conduct advertising. Accept all cookies to indicate that you agree to our use of cookies on your device.
Atlassian uses cookies to improve your browsing experience, perform analytics and research, and conduct advertising. Accept all cookies to indicate that you agree to our use of cookies on your device. Atlassian cookies and tracking notice, (opens new window)
SNOMED Spaces